Notably, some studies have found that plasma GFAP shows stronger associations with the Aβ burden, cognitive decline, and conversion from mild cognitive impairment (MCI) to AD than CSF GFAP [10,11]. This evidence concerns the gene GFAP and Alzheimer disease.